Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

Abstract Background Interleukin-6-receptor inhibitors like Tocilizumab and Satralizumab are showing promising results in the treatment of Neuromyelitis Optica spectrum disorder (NMOSD). We aimed to investigate the efficacy and safety of various Interleukin-6-receptor inhibitors in the management of...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanjeev Kharel, Suraj Shrestha, Rajeev Ojha, Neha Guragain, Rakesh Ghimire
Format: article
Language:EN
Published: BMC 2021
Subjects:
Online Access:https://doaj.org/article/f636e8b70e004c17b9339b5d2b02f9fa
Tags: Add Tag
No Tags, Be the first to tag this record!